Baidu
map

炎症性肠病(IBD)患者确诊后脊椎关节病发病率逐年增加

2012-07-12 吴莹莹 爱唯医学网

根据首项分析炎症性肠病(IBD)患者的脊椎关节病发病情况的人群研究结果,在诊断IBD后10年内,脊椎关节病的累计发病率为1/50,在诊断IBD后20和30年,发病率分别攀升到1/25和1/14。明尼苏达州罗彻斯特市梅奥医院风湿科主任Matteson医生及其同事分析了明尼苏达州Olmsted县1970~2004年间被诊断为IBD的居民的医疗记录。有311人被诊断为克罗恩氏病,365人被诊断为溃疡性结

根据首项分析炎症性肠病(IBD)患者的脊椎关节病发病情况的人群研究结果,在诊断IBD后10年内,脊椎关节病的累计发病率为1/50,在诊断IBD后20和30年,发病率分别攀升到1/25和1/14。

明尼苏达州罗彻斯特市梅奥医院风湿科主任Matteson医生及其同事分析了明尼苏达州Olmsted县1970~2004年间被诊断为IBD的居民的医疗记录。有311人被诊断为克罗恩氏病,365人被诊断为溃疡性结肠炎,对这些患者随访至2011年6月。诊断IBD时的中位年龄为33岁。

结果显示,在IBD之前被诊断为脊椎关节病的比例为1%。在确诊IBD后10年、20年和30年,脊椎关节病的累计发病率分别为2.3%、4.2%和7.1%。诊断IBD后10年时,强直性脊柱炎的累计发病率为0.2%,在诊断后20年升至0.7%。在诊断克罗恩氏病后10、20和30年,脊椎关节病的累计发病率分别为2.6%、6.1%和 9.8%;在诊断溃疡性结肠炎后10、20和30年,脊椎关节病的累计发病率分别为1.9%、2.8%和4.9%。

诊断IBD后才出现的脊椎关节病临床特征包括:少关节炎(3.1%)、多关节炎(1.3%)、骶髂关节炎(1.6%)、银屑病(2.2%)、葡萄膜炎(2.9%)、足底筋膜炎(5%)。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1823156, encodeId=471d18231560d, content=<a href='/topic/show?id=b2873e9220e' target=_blank style='color:#2F92EE;'>#发病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37922, encryptionId=b2873e9220e, topicName=发病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Mon Nov 05 11:12:00 CST 2012, time=2012-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1810308, encodeId=73e5181030897, content=<a href='/topic/show?id=ab9d8456981' target=_blank style='color:#2F92EE;'>#脊椎关节病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84569, encryptionId=ab9d8456981, topicName=脊椎关节病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca89104, createdName=huperzia, createdTime=Sun Jun 16 03:12:00 CST 2013, time=2013-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1263400, encodeId=83e112634001e, content=<a href='/topic/show?id=75bc930217' target=_blank style='color:#2F92EE;'>#IBD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9302, encryptionId=75bc930217, topicName=IBD)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc0372, createdName=bnurmamat, createdTime=Sat Jul 14 06:12:00 CST 2012, time=2012-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1546978, encodeId=d9eb15469e836, content=<a href='/topic/show?id=4ef26e01766' target=_blank style='color:#2F92EE;'>#炎症性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67017, encryptionId=4ef26e01766, topicName=炎症性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09e813968720, createdName=12498dd9m15暂无昵称, createdTime=Sat Jul 14 06:12:00 CST 2012, time=2012-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1630482, encodeId=bd891630482aa, content=<a href='/topic/show?id=dd238456e9f' target=_blank style='color:#2F92EE;'>#脊椎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84567, encryptionId=dd238456e9f, topicName=脊椎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f80c21536506, createdName=neizongke, createdTime=Sat Jul 14 06:12:00 CST 2012, time=2012-07-14, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1823156, encodeId=471d18231560d, content=<a href='/topic/show?id=b2873e9220e' target=_blank style='color:#2F92EE;'>#发病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37922, encryptionId=b2873e9220e, topicName=发病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Mon Nov 05 11:12:00 CST 2012, time=2012-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1810308, encodeId=73e5181030897, content=<a href='/topic/show?id=ab9d8456981' target=_blank style='color:#2F92EE;'>#脊椎关节病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84569, encryptionId=ab9d8456981, topicName=脊椎关节病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca89104, createdName=huperzia, createdTime=Sun Jun 16 03:12:00 CST 2013, time=2013-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1263400, encodeId=83e112634001e, content=<a href='/topic/show?id=75bc930217' target=_blank style='color:#2F92EE;'>#IBD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9302, encryptionId=75bc930217, topicName=IBD)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc0372, createdName=bnurmamat, createdTime=Sat Jul 14 06:12:00 CST 2012, time=2012-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1546978, encodeId=d9eb15469e836, content=<a href='/topic/show?id=4ef26e01766' target=_blank style='color:#2F92EE;'>#炎症性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67017, encryptionId=4ef26e01766, topicName=炎症性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09e813968720, createdName=12498dd9m15暂无昵称, createdTime=Sat Jul 14 06:12:00 CST 2012, time=2012-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1630482, encodeId=bd891630482aa, content=<a href='/topic/show?id=dd238456e9f' target=_blank style='color:#2F92EE;'>#脊椎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84567, encryptionId=dd238456e9f, topicName=脊椎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f80c21536506, createdName=neizongke, createdTime=Sat Jul 14 06:12:00 CST 2012, time=2012-07-14, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1823156, encodeId=471d18231560d, content=<a href='/topic/show?id=b2873e9220e' target=_blank style='color:#2F92EE;'>#发病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37922, encryptionId=b2873e9220e, topicName=发病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Mon Nov 05 11:12:00 CST 2012, time=2012-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1810308, encodeId=73e5181030897, content=<a href='/topic/show?id=ab9d8456981' target=_blank style='color:#2F92EE;'>#脊椎关节病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84569, encryptionId=ab9d8456981, topicName=脊椎关节病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca89104, createdName=huperzia, createdTime=Sun Jun 16 03:12:00 CST 2013, time=2013-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1263400, encodeId=83e112634001e, content=<a href='/topic/show?id=75bc930217' target=_blank style='color:#2F92EE;'>#IBD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9302, encryptionId=75bc930217, topicName=IBD)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc0372, createdName=bnurmamat, createdTime=Sat Jul 14 06:12:00 CST 2012, time=2012-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1546978, encodeId=d9eb15469e836, content=<a href='/topic/show?id=4ef26e01766' target=_blank style='color:#2F92EE;'>#炎症性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67017, encryptionId=4ef26e01766, topicName=炎症性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09e813968720, createdName=12498dd9m15暂无昵称, createdTime=Sat Jul 14 06:12:00 CST 2012, time=2012-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1630482, encodeId=bd891630482aa, content=<a href='/topic/show?id=dd238456e9f' target=_blank style='color:#2F92EE;'>#脊椎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84567, encryptionId=dd238456e9f, topicName=脊椎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f80c21536506, createdName=neizongke, createdTime=Sat Jul 14 06:12:00 CST 2012, time=2012-07-14, status=1, ipAttribution=)]
    2012-07-14 bnurmamat
  4. [GetPortalCommentsPageByObjectIdResponse(id=1823156, encodeId=471d18231560d, content=<a href='/topic/show?id=b2873e9220e' target=_blank style='color:#2F92EE;'>#发病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37922, encryptionId=b2873e9220e, topicName=发病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Mon Nov 05 11:12:00 CST 2012, time=2012-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1810308, encodeId=73e5181030897, content=<a href='/topic/show?id=ab9d8456981' target=_blank style='color:#2F92EE;'>#脊椎关节病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84569, encryptionId=ab9d8456981, topicName=脊椎关节病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca89104, createdName=huperzia, createdTime=Sun Jun 16 03:12:00 CST 2013, time=2013-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1263400, encodeId=83e112634001e, content=<a href='/topic/show?id=75bc930217' target=_blank style='color:#2F92EE;'>#IBD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9302, encryptionId=75bc930217, topicName=IBD)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc0372, createdName=bnurmamat, createdTime=Sat Jul 14 06:12:00 CST 2012, time=2012-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1546978, encodeId=d9eb15469e836, content=<a href='/topic/show?id=4ef26e01766' target=_blank style='color:#2F92EE;'>#炎症性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67017, encryptionId=4ef26e01766, topicName=炎症性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09e813968720, createdName=12498dd9m15暂无昵称, createdTime=Sat Jul 14 06:12:00 CST 2012, time=2012-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1630482, encodeId=bd891630482aa, content=<a href='/topic/show?id=dd238456e9f' target=_blank style='color:#2F92EE;'>#脊椎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84567, encryptionId=dd238456e9f, topicName=脊椎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f80c21536506, createdName=neizongke, createdTime=Sat Jul 14 06:12:00 CST 2012, time=2012-07-14, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1823156, encodeId=471d18231560d, content=<a href='/topic/show?id=b2873e9220e' target=_blank style='color:#2F92EE;'>#发病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37922, encryptionId=b2873e9220e, topicName=发病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Mon Nov 05 11:12:00 CST 2012, time=2012-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1810308, encodeId=73e5181030897, content=<a href='/topic/show?id=ab9d8456981' target=_blank style='color:#2F92EE;'>#脊椎关节病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84569, encryptionId=ab9d8456981, topicName=脊椎关节病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca89104, createdName=huperzia, createdTime=Sun Jun 16 03:12:00 CST 2013, time=2013-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1263400, encodeId=83e112634001e, content=<a href='/topic/show?id=75bc930217' target=_blank style='color:#2F92EE;'>#IBD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9302, encryptionId=75bc930217, topicName=IBD)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc0372, createdName=bnurmamat, createdTime=Sat Jul 14 06:12:00 CST 2012, time=2012-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1546978, encodeId=d9eb15469e836, content=<a href='/topic/show?id=4ef26e01766' target=_blank style='color:#2F92EE;'>#炎症性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67017, encryptionId=4ef26e01766, topicName=炎症性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09e813968720, createdName=12498dd9m15暂无昵称, createdTime=Sat Jul 14 06:12:00 CST 2012, time=2012-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1630482, encodeId=bd891630482aa, content=<a href='/topic/show?id=dd238456e9f' target=_blank style='color:#2F92EE;'>#脊椎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84567, encryptionId=dd238456e9f, topicName=脊椎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f80c21536506, createdName=neizongke, createdTime=Sat Jul 14 06:12:00 CST 2012, time=2012-07-14, status=1, ipAttribution=)]
    2012-07-14 neizongke

相关资讯

炎症性肠病治疗和癌症风险:何去何从?

 虽然最近在欧洲绝对年龄标准化癌症死亡率呈下降趋势,但是2004年癌症首次成为法国普通人群死亡的主要原因。非癌症类疾病的预后快速改善可以解释这种明显的矛盾。鉴于炎症性肠病(IBD)自然史和治疗的长期影响,癌症风险因此成为胃肠病学家和患者终生主要担心的问题。本文从IBD患者癌症总体死亡率、IBD和癌症之间的可能关系、免疫抑制疗法相关性癌症(淋巴组织增生性疾病、非黑色素瘤皮肤癌、子宫颈异常、

克罗恩病患者转归与专科护理的提高相关

来源:医学论坛网   加拿大学者Geoffrey C. Nguyen等,最近在《胃肠病学》(Gastroenterology)杂志上发表了一篇报道,说明在加拿大曼尼托巴省,与1996年之前诊断克罗恩病(CD)的患者相比,1996后的诊断者的手术风险降低,这种降低还与专科护理相关;诊断1年内进行专科护理有可能改善CD患者的转归。   研究者们对在1988年至2008年间在加拿大曼尼托巴省诊断为C

Baidu
map
Baidu
map
Baidu
map